n-(1-methyl-2-phenylethyl)adenosine has been researched along with acridine orange in 1 studies
Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (acridine orange) | Trials (acridine orange) | Recent Studies (post-2010) (acridine orange) |
---|---|---|---|---|---|
134 | 0 | 4 | 2,310 | 19 | 343 |
Protein | Taxonomy | n-(1-methyl-2-phenylethyl)adenosine (IC50) | acridine orange (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 0.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honda, Y; Kiryu, J; Miyamoto, K; Nishijima, K; Nishiwaki, H; Nonaka, A; Ogura, Y; Tsujikawa, A; Yamashiro, K | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and acridine orange
Article | Year |
---|---|
Inhibitory effect of ischemic preconditioning on leukocyte participation in retinal ischemia-reperfusion injury.
Topics: Acridine Orange; Adenosine; Animals; Fluorescein Angiography; Fluorescent Dyes; Injections, Intramuscular; Ischemic Preconditioning; Leukocytes; Male; Models, Animal; Purinergic P1 Receptor Antagonists; Rats; Rats, Long-Evans; Receptors, Purinergic P1; Reperfusion Injury; Retinal Diseases; Retinal Vessels; Xanthines | 2001 |